Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 5 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Grace Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 20 | 23 | +3 |
| Shares | 3.71M | 4.33M | +621.4K (+16.8%) |
| Value | $11.0M | $15.0M | +$3.96M (+35.9%) |
New holders (7)
Institutions that held Grace Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cerity Partners LLC | 422,732 | $1.46M | 0.00% |
| XTX Topco Ltd | 30,261 | $105.6K | 0.00% |
| Gsa Capital Partners LLP | 13,774 | $48.0K | 0.00% |
| Stratos Wealth Partners, LTD. | 11,182 | $38.7K | 0.00% |
| BNP Paribas Arbitrage, SA | 600 | $2.08K | 0.00% |
| Flagship Harbor Advisors, LLC | 2 | $7 | 0.00% |
| Motiv8 Investments LLC | 20 | $0 | 0.00% |
Sold out (4)
Institutions that held Grace Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Stonepine Capital Management, LLC | 211,010 | $628.2K |
| Millington Financial Advisors, LLC | 20,000 | $59.7K |
| SeaCrest Wealth Management, LLC | 14,000 | $42.0K |
| Citigroup Inc | 2,757 | $8.19K |